Journals / Medical Network Klinik Bilimler ve Doktor / 2004 / Cilt: 10 - Sayı: 6

Mushroom poisoning cases in our clinic between 1998-2004

1998-2004 yılları arasında kliniğimizde izlenen mantar zehirlenme olguları

Pages
608–611
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients suffering from acute hepatic failure or acut renal failure should go through activated choacoal hemodiaperfusion in addition to supportive treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Mushroom poisoning is an important health problem in Turkey.
📊
Key Findings & Data:Material and Methods: In this study 14 cases of mushroom poisoning were evaluated in our clinic between 1998-2004.
💡
Conclusion & Impact:Patients suffering from acute hepatic failure or acut renal failure should go through activated choacoal hemodiaperfusion in addition to supportive treatment.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Mantar zehirlenmesi · Geriyedönük çalışma · Kömür

Abstract

Objective: Mushroom poisoning is an important health problem in Turkey. The aim of this research is to examine and assess the progression of the cases involving mushroom poisoning and their treatment methods retrospectively. Material and Methods: In this study 14 cases of mushroom poisoning were evaluated in our clinic between 1998-2004. Reports of clinical findings, blood chemistry, hemocounts, abdominal sonography, period of hospitalization and their treatment were investigated from medical records. Results: The most ordinary symptoms observed in the cases were nausea, vomiting, diarrhoea. In all cases, symptoms revealed in 4-8 hours after they had mushroom. In three cases of all laboratory findings were normal, in other three cases in liver functional tests values were 3 or 4 times higher, in one case acute renal failure, in one case acute hepatitis, in three cases acute hepatitis plus acute renal failure, in three cases acute hepatic failure plus acute renal failure were diagnosed. It has been clarified in our research two of the patients lost their lives and the other twelwe patients completely recovered. Conclusion: For the fact that antidote is not available in the market, supportive treatment is applied for mushroom poisoning. Patients suffering from acute hepatic failure or acut renal failure should go through activated choacoal hemodiaperfusion in addition to supportive treatment.

Özet

Amaç: Mantar zehirlenmeleri ülkemizde önemli bir sağlık sorunudur. Bu çalışmanın amacı; mantar zehirlenmesi nedeni ile yatan hastaların kayıtlarını retrospektif olarak inceleyerek progresyon ve tedavi yöntemlerini değerlendirmektir. Gereç ve Yöntem: Bu çalışmada kliniğimizde 1998-2004 yılları arasında mantar zehirlenmesi nedeni ile yatan 14 hastanın kayıtları retrospektif olarak incelendi. Hastaların fizik muayene bulguları, rutin biyokimyasal testleri, hemogram değerleri, viral hepatit panelleri, batın ultrasonografileri, hastanede yatış süreleri ve tedavileri araştırıldı. Bulgular: Hastalarda en çok görülen semptomlar bulantı, kusma, ishaldi. Tüm hastalarda, ilk semptomlar mantar alımından 4-8 saat sonra ortaya çıkmıştı. Üç olguda tüm laboratuvar bulguları normalken, 3 olguda karaciğer fonksiyon testlerinde (KCFT) 3-4 kat yükselme, 1 olguda akut böbrek yetmezliği (ABY), 1 olguda akut hepatit, 3 olguda akut hepatit +ABY, 3 olguda ise akut karaciğer yetmezliği+ABY mevcuttu. Çalışmamızda 2 olgunun (%14) öldüğü, 12 olgunun (%88) tamamen iyileştiği saptandı. Sonuç: Mantar zehirlenmelerinde antidot olmaması nedeni ile destek tedavi uygulanmaktadır. Akut karaciğer yetmezliği ve ABY'li hastalarda destek tedavinin yanında, aktif kömürlü hemodiyaperfüzyon uygulaması yapılmalıdır.

🔖

Cite This Article

PİLANCI, A., HARMANDA, A., SOYSAL, D. (2004). Mushroom poisoning cases in our clinic between 1998-2004. Medical Network Klinik Bilimler ve Doktor, Cilt: 10 - Sayı: 6, 608–611. https://ajindex.com/articles/266076

References (1)

  1. Lampe KF, Me Cann MA. Differential diagnosis of poisinir by North American mushrooms, with particular emphasis c amanita phalloides-like intoxication. Ann Emergency Med 198 16:956-62. 2.Zanotti G, Petersen G, Wieland T. Structure-toxici relationships in the amatoxin series. Structural variations of si_____ chain 3 and inhibation of RNA polymerase II. Int J Peptii Protein Res 1992; 40:551-8. 3.Vesconi S, et al. Therapy of cytotoxic mushroom intoxicatic Crit Care Med 1985; 13:402-6. 4.Weiland T. Poisonous principles of mushrooms of the gen amanita. Science 1968; 159:946-52. 5.Unluoglu I, Tayfur M. Mushroom poisoning: an analysis the data between 1996 and 2000. Eur J Emerg Med 20i 10:23-6. 6.Unluoglu I, Alper Çevik A, Bor O, Tayfur M, Şahin Mushroom poisonings in children in Central Anatolia. Vet H Toxicol. 2004; 46:134-7. 7.Paydaş S, Kocak R, Erturk F, Erken E, Aksu HS, Gurca Poisoning due to amatoxin-containing Lepiota species. Br J ( Pract. 1990; 44:450-3. 8.Montanini S, Sinardi D, Practico C. Use of acetylcysteine the life-saving antidote in Amanita phalloides poisoning. C report on 11 patients. Arzneimittelforschung 1999; 49:100-47 9.Klein AS, et al. Amanita poisoning: treatment and the rol liver transplantation. Am J Med 1989; 86:187-93. 10.Floersheim GL Treatment of human amatoxin mushn poisoning: myths and advances in therapy. Med Toxicol 1! 2:1-9.; 11.Öztekin-Mat A. Mushroom poisining in Turkey. Ann Pr Fr. 1998; 56:233-5. 12.Leathern AM, Purssell RA, Chan VR, Kroeger PD. R failure caused by mushroom poisining. J Toxicol Clin To 1997; 35:67-75. 13.Rengstorff DS,. Osorio RW, Bonacini M. Recovery severe hepatitis caused by mushrooms poisoning without transplantation. Clin Gastroenterol Hepatol 2003; 1:392-6. 14.Jander S, Bischoff J, Woodcock BG. Plasmaphresis ii treatment of Amanita phalloides poisoning: A review recommendations. Ther Apher 2000; 4:308-12. 15.Bektaş. H, Schlitt HJ, Boker K. Indications for transplantation in severe amanita phalloides mush poisoning, Çhirurg 1996; 67:996-1001.